- Nachrichtendetail
-
11.06.2024 13:04:01 - dpa-AFX: *REGENERON AND SANOFI: FDA APPROVES KEVZARA FOR TREATMENT OF ACTIVE POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
SANOFI SA INHABER EO 2 | 920657 | Frankfurt | 91,120 | 01.07.24 08:07:14 | +1,320 | +1,47% | 90,820 | 91,720 | 90,000 | 89,800 |
|
REGENERON PHARMAC.DL-,001 | 881535 | Frankfurt | 995,000 | 01.07.24 08:01:33 | +18,400 | +1,88% | 981,800 | 987,000 | 995,000 | 976,600 |
